7 C
New York
Saturday, December 2, 2023

There’s No Getting Around Surgepays Inc (NASDAQ: SURG) Success

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Surgepays Inc (SURG) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.17, or 2.67%, to $6.53. The Surgepays Inc has recorded 978 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted SurgePays Announces Record Third Quarter 2023 Financial Results.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

SURG belongs to the Technology sector of the NASDAQ while operating in the Software – Application industry. At the end of the last regular session, the stock closed at $6.36 and fluctuated between $6.59 as its day high and $6.01 as its day low. The current market capitalization of Surgepays Inc is $90.50M. A total of 0.61 million shares were traded on the day, compared to an average of 118.84K shares.

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, SURG has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 6 BUYs and 0 SELLs from insiders. Insiders purchased 1,150,200 shares during that period but sold 0.

In the most recent transaction, Cox Kevin Brian bought 5,200 shares of SURG for 4.72 per share on Aug 15. After the transaction, the CHIEF EXECUTIVE OFFICER now owns 4,507,894 company shares.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for SURG in the last 3 months, the mean price target is $13.00 with high estimates of $15.00 and low estimates of $11.00. In terms of 52-week highs and lows, SURG has a high of $8.33 and a low of $3.88.

As of this writing, SURG has an earnings estimate of $0.34 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of $0.51 per share and a lower estimate of $0.17. The company reported an EPS of $0.4 in the last quarter, which was 166.70% higher than expectations of $0.15.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SURG’s latest balance sheet shows that the firm has $6.28M in Cash & Short Term Investments as of fiscal 2021. There were $7.68M in debt and $10.00M in liabilities at the time. Its Book Value Per Share was $1.65, while its Total Shareholder’s Equity was $3.55M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SURG is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles